Are we investing in sexual and reproductive health products that people want to use?
On World Contraception Day, the importance of choice in the realm of sexual and reproductive health cannot be overstated Comprehensive sexual and reproductive health [...]
Food and Drug Administration (FDA) Approves the Nonprescription use of Opill
The Population Council congratulates the team behind the Opill development for achieving Food & Drug Administration approval of Opill, a progestin-only oral contraceptive, for [...]
New Ideas & Collective Guidance: An Overview of the 2023 International Committee for Contraception Research (ICCR) Meeting
The Population Council’s International Committee for Contraception Research (ICCR) welcomed a global consortium of clinical scientists, endocrinologists, gynecologists, and andrologists to discuss novel contraceptive [...]
Our Statement of Support for Over-the-Counter Access to a Progestin-only Pill
The Population Council believes that there is compelling effectiveness and safety data to support over-the-counter (OTC) status for oral contraception progestin-only pills (POP), such [...]
A Nestorone-Only Vaginal Ring for Contraception
Identifying gaps within current contraceptive options is essential to expanding access for all individuals. Currently, several contraceptives provide limited options for individuals with estrogen [...]
Dual Prevention Pill for the Prevention of HIV and Unintended Pregnancy
Young women worldwide are confronted with two significant health risks: unintended pregnancy and HIV infection. Oral pre-exposure prophylaxis (PrEP) is a highly effective method [...]
A Conversation with Régine Sitruk-Ware
Régine Sitruk-Ware, distinguished scientist at the Population Council, is the recipient of the 2022 Society of Family Planning Lifetime Achievement Award. The honor is [...]
World Contraception Day
From IUDs to implants and vaginal rings, our Center for Biomedical Research (CBR) has brought nine products to market. More than 170 million women [...]